Triamterene and Hydrochlorothiazide
- Product NDC
- 53002-1252
- 11-digit product format
- 530021252
- Labeler code
- 53002
- Product ID
- 53002-1252_1122ea94-c817-47b5-b79b-ebc5305e9e68
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA073449
- Marketing category
- ANDA
- Marketing start
- 1993-09-23
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 38 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-1252-0 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-0 | 2023-06-08 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-3 | 2023-06-08 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-0 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-3 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-0 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-3 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
| 53002-1252-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-432a-f424-e053-dadaa90a57ce | Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1252-0 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 53002-1252-3 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1252 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 2 package rows | 20230609_f7078eb5-f5fa-4067-94c5-93c1650db52c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1252-0 | 53002125200 | 100 TABLET in 1 BOTTLE (53002-1252-0) | 100 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1252-3 | 53002125203 | 30 TABLET in 1 BOTTLE (53002-1252-3) | 30 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |